These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24078817)

  • 1. A simple methodology for conversion of mouse monoclonal antibody to human-mouse chimeric form.
    Dang VT; Mandakhalikar KD; Ng OW; Tan YJ
    Clin Dev Immunol; 2013; 2013():716961. PubMed ID: 24078817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
    Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
    Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies against ganglioside expressed on tumor cells.
    Hanai N; Nakamura K; Shitara K
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully human therapeutic monoclonal antibodies.
    Weiner LM
    J Immunother; 2006; 29(1):1-9. PubMed ID: 16365595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction and clinical application of chimeric antibodies].
    Kuroki M; Arakawa F; Haruno M
    Nihon Rinsho; 1995 Dec; 53(12):3122-31. PubMed ID: 8577069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.
    Kapelski S; Boes A; Spiegel H; de Almeida M; Klockenbring T; Reimann A; Fischer R; Barth S; Fendel R
    Malar J; 2015 Feb; 14():50. PubMed ID: 25651860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments.
    Pluschke G; Joss A; Marfurt J; Daubenberger C; Kashala O; Zwickl M; Stief A; Sansig G; Schläpfer B; Linkert S; van der Putten H; Hardman N; Schröder M
    J Immunol Methods; 1998 Jun; 215(1-2):27-37. PubMed ID: 9744745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering fully human monoclonal antibodies from murine variable regions.
    Bernett MJ; Karki S; Moore GL; Leung IW; Chen H; Pong E; Nguyen DH; Jacinto J; Zalevsky J; Muchhal US; Desjarlais JR; Lazar GA
    J Mol Biol; 2010 Mar; 396(5):1474-90. PubMed ID: 20045416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibodies from transgenic mice.
    Lonberg N
    Handb Exp Pharmacol; 2008; 181(181):69-97. PubMed ID: 18071942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse.
    Boado RJ; Zhang Y; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2009 Mar; 102(4):1251-8. PubMed ID: 18942151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of chicken-mouse chimeric antibody and immunogenicity in mice.
    Tateishi Y; Nishimichi N; Horiuchi H; Furusawa S; Matsuda H
    J Vet Med Sci; 2008 Apr; 70(4):397-400. PubMed ID: 18460836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of a new chimeric antibody against HER2.
    Amiri MM; Jeddi-Tehrani M; Kazemi T; Bahadori M; Maddah M; Hojjat-Farsangi M; Khoshnoodi J; Rabbani H; Shokri F
    Immunotherapy; 2013 Jul; 5(7):703-15. PubMed ID: 23829622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vector construction and expression of anti-Aβ human-mouse chimeric antibody against Alzheimer's disease].
    Chang D; Zhang JH; Zhao XM; Liang P
    Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):542-7. PubMed ID: 21055034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering antibodies for therapy.
    Mountain A; Adair JR
    Biotechnol Genet Eng Rev; 1992; 10():1-142. PubMed ID: 1301737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of engineered antibodies.
    Hwang WY; Foote J
    Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
    Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
    Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of humanized antibodies as cancer therapeutics.
    Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
    Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of a chimeric antibody directed against the human transferrin receptor.
    Hoogenboom HR; Raus JC; Volckaert G
    J Immunol; 1990 Apr; 144(8):3211-7. PubMed ID: 2324499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and expression of human-mouse chimeric antibody against human CD40].
    Qu QX; Chen YJ; Ge Y; Wang Q; Chen C; Yang MF; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):189-92. PubMed ID: 16507256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.